Source: STAT News

Corbus, LLC.: STAT+: With expectations rising, Corbus reveals new data on its ADC bladder cancer treatment

ASCO 2024: Corbus, reporting on early trials of its antibody-drug conjugate, says it "seems to be clinically effective in bladder cancer."

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Suresh Iyer's photo - President & CEO of Corbus, LLC.

President & CEO

Suresh Iyer

CEO Approval Rating

51/100

Read more